Experimental and Clinical Endocrinology & Diabetes

Issue S 04 · Volume 107 · 1999 DOI: 10.1055/s-002-19253

S115

Home, P. D.: Rapid-acting insulin secretagogues: a clinical need?

S120

Massi-Benedetti, M.; Orsini Federici, M.: Cardiovascular risk factors in Type 2 diabetes: the role of hyperglycaemia

S124

Polonsky, K. S.: Evolution of β-cell dysfunction in impaired glucose tolerance and diabetes

S128

Landgraf, R.: Approaches to the management of postprandial hyperglycaemia

S133

Gomis, R.: Repaglinide as monotherapy in Type 2 diabetes

S136

Moses, R.: Repaglinide in combination therapy with metformin in Type 2 diabetes

S140

Malaisse, W. J.: Mechanism of action of a new class of insulin secretagogues

S144

Schatz, H.: Preclinical and clinical studies on safety and tolerability of repaglinide